Doubled dosage of sofosbuvir is expected for inhibiting Zika virus infection

Journal Title: Asian Pacific Journal of Tropical Medicine - Year 2017, Vol 10, Issue 6

Abstract

Sofosbuvir is a new antiviral drug that has been recommended for management of hepatitis C virus (HCV) for a few years. New researches support that sofosbuvir might be useful for the management of Zika virus infection. Based on the pharmacological activity, inhibiting the HCV RNA-dependent RNA polymerase (RdRp or NS5 protein), sofosbuvir is proposed for its effectiveness against Zika virus infection. Here, the authors used a mathematical modelling theoretical approach to predict the expected dosage of sofosbuvir for inhibiting Zika virus infection. Based on the modeling study, if sofosbuvir is assigned for management of Zika virus infection, doubled dosage of the present dosage for hepatitis C management is recommended.

Authors and Affiliations

Somsri Wiwanitkit

Keywords

Related Articles

Leishmaniases: Still alarming at 2018 in Bangladesh

All over the world approximately 98 countries faces endemic outbreak of leishmaniases, which is a group of parasitic disease. More than 350 million people reside under the risk of these diseases and new cases per year is...

Fructose 1,6-diphosphate alleviates myocardial ischemia reperfusion injury in rats through JAK2/STAT3 pathway

Objective: To study the effect of fructose 1,6-diphosphate (FDP) on myocardial ischemia reperfusion injury in rats and its molecular mechanism. Methods: Male SPF SD rats were selected as experimental animals and randomly...

Rosmarinic acid attenuates hepatic fibrogenesis via suppression of hepatic stellate cell activation/proliferation and induction of apoptosis

Objective: To investigate the antifibrotic role of rosmarinic acid (RA), a natural polyphenolic compound, on HSCs activation/proliferation and apoptosis in vitro and in vivo. Methods: The impact of RA on stellate cell li...

Role of NF- κ B signaling pathway in airway inflammation of rats induced by atmospheric PM25

Objective: To define the effect of PM2.5 exposure on NF- κ B signaling pathway and airway inflammation, and to reveal the role of NF- K B signaling pathway in airway inflammation induced by atmospheric PM2.5 in rats. Air...

Evaluation of in vitro and in vivo immunostimulatory activities of poly (lactic-co-glycolic acid) nanoparticles loaded with soluble and autoclaved Leishmania infantum antigens: A novel vaccine candidate against visceral leishmaniasis

Objective: To prepare and characterize poly lactic-co-glycolic acid (PLGA) nanoparticles loaded with soluble leishmanial antigen or autoclaved leishmanial antigen and explore in vitro and in vivo immunogenicity of antige...

Download PDF file
  • EP ID EP267441
  • DOI 10.1016/j.apjtm.2017.06.012
  • Views 104
  • Downloads 0

How To Cite

Somsri Wiwanitkit (2017). Doubled dosage of sofosbuvir is expected for inhibiting Zika virus infection. Asian Pacific Journal of Tropical Medicine, 10(6), 612-613. https://europub.co.uk/articles/-A-267441